Literature DB >> 23392715

Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma.

Yan-Feng Pan1, Tao Qin2, Lei Feng3, Zu-Jiang Yu3.   

Abstract

In China, hepatitis B virus (HBV) infection is the major cause of hepatocellular carcinoma (HCC), which is called HBV-related HCC (HBV-HCC), but the pathogenesis has not been clearly elucidated. Long non-coding RNAs (lncRNAs) have been paid increasing attention to, as an important regulatory molecule involved in many biological processes, as well as a variety of diseases. This study examined lncRNA that might play an important role in HBV-HCC pathogenesis by conducting lncRNA and mRNA profile comparison between HBV-HCC and normal liver tissues. The differentially expressed lncRNA and mRNA profiles between HBV-HCC and normal liver tissues were analyzed by microarrays. The potential protein-encoding gene regulated by lncRNA, and the biological function (gene ontology, pathway analysis) of the target gene were investigated. The results showed that the expression levels of lncRNA and mRNA in HBV-HCC tissues were different from those in normal liver tissues. As compared with normal liver tissue, 837 (4.30%) lncRNAs exhibited more than two-fold change (P<0.05); 325 were up-regulated, and 512 were down-regulated; 991 (5.70%) mRNAs exhibited more than 2-fold change (P<0.05); 733 were up-regulated and 258 were down-regulated in HBV-HCC tissue. Besides, there were 7 lncRNAs with above 10-fold elevation, 6 lncRNAs with above 10-fold decrease, 18 mRNAs with above 10-fold elevation and 11 mRNAs with above 10-fold decrease. 444 (53.05%) lncRNAs had their corresponding mRNAs, some of which were adjacent to lncRNAs. The biological analysis showed that the target gene of differentially expressed lncRNAs took part in the important biological regulatory function. Target gene-related pathway analysis revealed the pathways in carcinoma and mitogen-activated protein kinase (MAPK) signaling pathways significantly changed in the HBV-HCC tissues as compared with normal liver tissues (P<0.05). It was suggested that as compared with normal liver tissues, the expression of lncRNAs in HBV-HCC tissues changed significantly, and lncRNAs played a key role in the pathogenesis of HBV-HCC probably by mainly regulating the carcinoma-related signaling pathway and MAPK signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392715     DOI: 10.1007/s11596-013-1078-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  24 in total

1.  The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation.

Authors:  Jin-Ping Lai; Abdul M Oseini; Catherine D Moser; Chunrong Yu; Sherine F Elsawa; Chunling Hu; Ikuo Nakamura; Tao Han; Ileana Aderca; Hajime Isomoto; Megan M Garrity-Park; Abdirashid M Shire; Jia Li; Schuyler O Sanderson; Alex A Adjei; Martin E Fernandez-Zapico; Lewis R Roberts
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

2.  RNAplex: a fast tool for RNA-RNA interaction search.

Authors:  Hakim Tafer; Ivo L Hofacker
Journal:  Bioinformatics       Date:  2008-04-23       Impact factor: 6.937

3.  Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.

Authors:  Katrin Panzitt; Marisa M O Tschernatsch; Christian Guelly; Tarek Moustafa; Martin Stradner; Heimo M Strohmaier; Charles R Buck; Helmut Denk; Renée Schroeder; Michael Trauner; Kurt Zatloukal
Journal:  Gastroenterology       Date:  2006-08-14       Impact factor: 22.682

4.  Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma.

Authors:  Hasan Ozkan; Harun Erdal; Erdem Koçak; Hüseyin Tutkak; Zihni Karaeren; Mustafa Yakut; Seyfettin Köklü
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

Review 5.  The role of signaling pathways in the development and treatment of hepatocellular carcinoma.

Authors:  S Whittaker; R Marais; A X Zhu
Journal:  Oncogene       Date:  2010-07-19       Impact factor: 9.867

Review 6.  Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma.

Authors:  Mary Maluccio; Anne Covey
Journal:  CA Cancer J Clin       Date:  2012-10-15       Impact factor: 508.702

7.  Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression.

Authors:  Ahmad M Khalil; Mitchell Guttman; Maite Huarte; Manuel Garber; Arjun Raj; Dianali Rivea Morales; Kelly Thomas; Aviva Presser; Bradley E Bernstein; Alexander van Oudenaarden; Aviv Regev; Eric S Lander; John L Rinn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

8.  A novel function of YWHAZ/β-catenin axis in promoting epithelial-mesenchymal transition and lung cancer metastasis.

Authors:  Ching-Hsien Chen; Show-Mei Chuang; Meng-Fang Yang; Jiunn-Wang Liao; Sung-Liang Yu; Jeremy J W Chen
Journal:  Mol Cancer Res       Date:  2012-08-21       Impact factor: 5.852

9.  Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin.

Authors:  Eun-Ju Lee; Minwha Jo; Seung Bae Rho; Kyoungsook Park; Yae-Na Yoo; Junsoo Park; Myounghee Chae; Wei Zhang; Je-Ho Lee
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

Review 10.  The functional role of long non-coding RNA in human carcinomas.

Authors:  Ewan A Gibb; Carolyn J Brown; Wan L Lam
Journal:  Mol Cancer       Date:  2011-04-13       Impact factor: 27.401

View more
  18 in total

1.  Differential expression of genes in HepG2 cells caused by UC001kfo RNAi as shown by RNA-seq.

Authors:  Yan-Feng Pan; Tong Su; Li-Dan Chen; Tao Qin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

2.  Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients.

Authors:  Sien Guo; Wenjie Chen; Yihuan Luo; Fanghui Ren; Tengfei Zhong; Minhua Rong; Yiwu Dang; Zhenbo Feng; Gang Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  The HBV Specially-Related Long Noncoding RNA HBV-SRL Involved in the Pathogenesis of Hepatocellular Carcinoma.

Authors:  Cunzhen Zhang; Lei Lu; Haibei Xin; Minfeng Zhang; Zhiwen Ding; Qiaomei Li; Kuang Chen; Minggen Hu; Shupeng Liu; Nan Li
Journal:  J Oncol       Date:  2022-07-08       Impact factor: 4.501

Review 4.  Long noncoding RNA in liver diseases.

Authors:  Kenji Takahashi; Irene Yan; Hiroaki Haga; Tushar Patel
Journal:  Hepatology       Date:  2014-06-20       Impact factor: 17.425

5.  The Differential Expression and Possible Function of Long Noncoding RNAs in Liver Cells Infected by Dengue Virus.

Authors:  Xiao-Jun Wang; Shi-Chen Jiang; Hai-Xia Wei; Sheng-Qun Deng; Cheng He; Hong-Juan Peng
Journal:  Am J Trop Med Hyg       Date:  2017-09-28       Impact factor: 2.345

6.  HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus.

Authors:  Zongguo Yang; Yunfei Lu; Qingnian Xu; Bozong Tang; Cheol-Keun Park; Xiaorong Chen
Journal:  Dis Markers       Date:  2015-06-07       Impact factor: 3.434

7.  CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA.

Authors:  Alice Conigliaro; Viviana Costa; Alessia Lo Dico; Laura Saieva; Simona Buccheri; Francesco Dieli; Mauro Manno; Samuele Raccosta; Carmine Mancone; Marco Tripodi; Giacomo De Leo; Riccardo Alessandro
Journal:  Mol Cancer       Date:  2015-08-14       Impact factor: 27.401

8.  Genome-wide analysis of long noncoding RNA (lncRNA) expression in hepatoblastoma tissues.

Authors:  Rui Dong; Deshui Jia; Ping Xue; Ximao Cui; Kai Li; Shan Zheng; Xianghuo He; Kuiran Dong
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

9.  Long Noncoding RNAs in Interaction With RNA Binding Proteins in Hepatocellular Carcinoma.

Authors:  Ashraf Mohamadkhani
Journal:  Hepat Mon       Date:  2014-05-05       Impact factor: 0.660

10.  A Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection.

Authors:  Da-Wu Zeng; Jie-Min Zhang; Yu-Rui Liu; Jing Dong; Jia-Ji Jiang; Yue-Yong Zhu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.